Join the waitlist

Planned for launch

Compare treatments.

The 6 treatments planned for prescription at launch. Your clinician decides what, if anything, is right for you.

TreatmentTypeFDA-approved useHow it’s takenBoxed warning
SemaglutideFDA-approved · by prescriptionFDA-approved as Ozempic, Rybelsus and Wegovy for type 2 diabetes and chronic weight management, among other indications.Injection under the skin, or tabletYes. Risk of thyroid C-cell tumors: semaglutide caused thyroid C-cell tumors in rodents, and whether it does so in humans is unknown. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
TirzepatideFDA-approved · by prescriptionFDA-approved as Mounjaro and Zepbound for type 2 diabetes and chronic weight management, among other indications.Injection under the skinYes. Risk of thyroid C-cell tumors: tirzepatide caused thyroid C-cell tumors in rodents, and whether it does so in humans is unknown. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
PT-141 (Bremelanotide)FDA-approved · by prescriptionBremelanotide (Vyleesi) is FDA-approved to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women; it is not approved for men or postmenopausal women.Injection under the skinNo
GHK-CuCompounded · topical · not FDA-approvedNone. Compounded medications are not FDA-approved.Topical, applied to the skinNo
SermorelinCompounded · not FDA-approvedNone. Compounded medications are not FDA-approved.Injection under the skinNo
TesamorelinFDA-approved · by prescriptionTesamorelin (Egrifta, Egrifta SV and Egrifta WR) is FDA-approved to reduce excess abdominal visceral fat in adults with HIV who have lipodystrophy; it is not approved for general weight loss.Injection under the skinNo